Sickle Cell Anemia Guidance Expands Hydroxyurea Access
WHO recommends universal hydroxyurea treatment for children with sickle cell anemia from 9 months through age 19, emphasizing early care and stronger health-system support.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.